Skip to search.
 BSE Down 1.07% NSE Down 1.11%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
10.81 Down 0.40(3.53%) 25 Apr 1:30AM
|After Hours : 10.81 Up 0.00 (0.02%) 25 Apr 1:48AM
Add to Portfolio
Prev Close:11.21
Open:11.19
Bid:10.80 x 2000
Ask:11.20 x 200
1y Target Est:16.67
Beta:0.54
Earnings Date:6 May - 11 May (Est.)
Day's Range:10.79 - 11.24
52wk Range:2.31 - 14.40
Volume:1,854,790
Avg Vol (3m):4,753,370
Market Cap:1.38B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 3.53%1.38B
IMGNDown 2.83%857.64M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):851.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.13
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback